The Entrepreneur'sRESOURCE

Explore the Resource Center to find resources.  Designed with entrepreneurs in mind, our resource center allows you to find materials to grow great ideas.

Event Preview: MedTech Investing Conference

Christina Hernandez Sherwood, eMed Editor, MedCity News

Medical technology innovators and investors from across the country will gather Wednesday in Minneapolis for the 12th annual MedTech Investing Conference. With panels on alternative funding models, maximizing ROI, and the FDA on the agenda, we asked conference co-chair Dennis Wahr, CEO of Holaira, what insights life science and digital health entrepreneurs can expect to take away from the event.

The medical technology landscape is changing, Wahr said, as a greater emphasis is placed on efficacy, treatment effect, and cost efficiency. At the same time, he said, financing sources are shrinking, particularly in venture capital, because the regulatory and quality bars have been raised. “All of that paints a much more challenging environment,” Wahr said. But he added there’s no question the medical technology field will continue evolving. The main theme of Wednesday’s conference, Wahr said, is what’s happening that will make the industry thrive, despite these challenges.

While each of Wednesday’s sessions will be relevant to entrepreneurs on some level, Wahr pointed out a few potential standouts:

  • The Great Debate and Alternative Funding Models: These two sessions on funding will focus on early- and late-stage investing, as well as emerging funding sources available to private companies, shedding light for entrepreneurs on how investors decide where to invest.
  • Alternative Clinical Product and Development Models: This session, moderated by Wahr, will show entrepreneurs how to develop a new clinical product that enhances the potential for success, despite higher regulatory and treatment effect bars.
  • An Insider’s Look at the FDA: This interview with Dr. Jeffrey E. Shuren, director of the FDA’s Center for Devices and Radiological Health, will offer insights on key reforms and priorities of the FDA as it relates to the med tech industry. “What I think people will hear is that the FDA, while they’re strict, has a real interest in seeing beneficial technologies brought forward,” Wahr said.

The full conference agenda is available here. eMed will be on hand Wednesday to cover the event, so check back later this week for updates from the conference.

comments powered by Disqus

Search for Resources

Stay Connected

Email Newsletter Signup

Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.

Email Newsletters

Want to be up-to-date with the latest news and updates from To subscribe, just give us your email address below; you'll choose which e-newsletters you'd like to receive on the next screen.